GHRP-2
Also known as: Growth Hormone Releasing Peptide-2
GHRP-2 (pralmorelin) is a synthetic hexapeptide ghrelin receptor agonist that stimulates pituitary growth hormone release. It is approved in Japan (Kaken Pharmaceutical, 2004) as a single-dose diagnostic agent for GH deficiency, but is NOT FDA-approved in the US and is research-only. Unlike ipamorelin, GHRP-2 is non-selective and modestly raises ACTH, cortisol, and prolactin.
Who's worth your money for GHRP-2
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
Top Merit pick
Highest Merit Score (98) of 8 scored sellers
$16.00 · 5mg · 99.3% purity
Best value
Lowest $/mg among scored sellers
$22.99 · 11.13mg · 99.4% purity
Most tested
2 independent COAs on file
$46.00 · 10mg · 98.2% purity
Average price
$3.67/mg
Sellers
23
45-day trend
-21.3%
16 of 23 sellers have a current price· 2 stale hidden· 6 unverified hidden
Top Merit pick
🇺🇸 Moglabs98via Disclosed Labs · 1h ago
$3.20/mg -12.9% vs avg$16.00
5mg
- 🇺🇸 Certified Peptides94
✓ verified at source · 1h ago
$4.60/mg +25.2% vs avg$46.00
10mg
- 🇺🇸 Soma Peptides89
✓ verified at source · 1h ago
$4.40/mg +19.8% vs avg$44.00
10mg
- 🇺🇸 Ruo Bio88
✓ verified at source · 1h ago
$2.80/mg -23.8% vs avg$14.00
5mg
- 🇺🇸 Verified Peptides86
via Disclosed Labs · 1h ago
$3.00/mg -18.3% vs avg$30.00
10mg
- 🇺🇸 Simple Peptide85
via Disclosed Labs · 1h ago
$3.90/mg +6.2% vs avg$39.00
10mg
- Modern Research Peptides82
via Disclosed Labs · 1h ago
$2.07/mg -43.8% vs avg$22.99
11.13mg
- 🇺🇸 Genetic Peptide71
✓ verified at source · 23h ago
$4.00/mg +8.9% vs avg$40.00
10mg
no purity
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
Watch GHRP-2
Get one email when the market actually moves — no newsletter, no noise.
About GHRP-2
CAS
158861-67-7
Molecular formula
C45H55N9O6
Sequence
AAWFK
Typical dose range
100–300 mcg per injection, 2–3x daily, subcutaneous
Half-life
~15–30 minutes
COAs for GHRP-2
24 third-party tests across 10 vendors. Each card links to the full report.
For
GHRP-2
by Ion Peptide· batch G25-06092026
For
GHRP-2
by Ion Peptide· batch G25-06092026
For
GHRP-2
by Moglabs· batch GH202
For
GHRP-2
by Simple Peptide· batch GHRP2-100032026-1
For
GHRP-2
by Peptidology· batch 1672
For
GHRP-2
by Simple Peptide· batch GHRP2-022026
For
GHRP-2
by Modern Research Peptides· batch G210261
For
GHRP-2
by Ion Peptide· batch GHP25-01272026
For
GHRP-2
by Ion Peptide· batch GH2-5-122825
For
GHRP-2
by Ion Peptide· batch GH2-S-122825
For
GHRP-2
by Moglabs· batch hg2001
For
GHRP-2
by Moglabs· batch hg2001
For
GHRP-2
by Ruo Bio· batch hg2001
For
GHRP-2
by Kimera Chems· batch White Cap
For
GHRP-2
by Soma Peptides· batch GHX102401
For
GHRP-2
by Peptide Tech· batch G2-001
For
GHRP-2
by Ion Peptide· batch GHP25-01272026
For
GHRP-2 Acetate
by Real Peptides· batch RP052226
For
GHRP-2
by Real Peptides· batch BATCH-0322
For
GHRP-2
by Certified Peptides· batch GHRP2070726
Purity not on file
For
GHRP-2
by Verified Peptides· batch G208260610F
Purity not on file
For
GHRP-2
by Certified Peptides· batch GHRP21025
Purity not on file
For
GHRP-2
by Ruo Bio
Purity not on file
For
GHRP-2
by Moglabs
12 citations indexed for GHRP-2
Study · 2026
Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of the corticotropin-releasing hormone and growth hormone-releasing peptide-2 stimulation tests
In Japan, the Corticotropin-releasing hormone (CRH) stimulation test is widely used to evaluate secondary adrenal insufficiency (SAI); however, the insulin tolerance test (ITT) is sometimes required to assess hypothalamic dysfunction.
Study · 2026
Chronic Central Adrenal Insufficiency in a Patient With Remote Traumatic Brain Injury and an Apparently Adequate Standard-Dose ACTH Response: A Case Report
In patients with a remote history of traumatic brain injury, central adrenal insufficiency may remain unrecognized for decades.
case-report · 2026
Reversible predominant thyrotropin axis dysfunction with meningitis in suspected lymphocytic hypophysitis
Lymphocytic hypophysitis (LYH), attributed to autoimmune mechanisms, typically causes multiple anterior pituitary hormone deficiencies, with corticotroph dysfunction occurring earliest; predominant thyrotroph dysfunction is uncommon. A 65-year-old woman presented with headache, fever, and diplopia.
case-report · 2026
Coexisting mild autonomous cortisol secretion and isolated adrenocorticotropic hormone deficiency in a patient with an adrenal incidentaloma
Low adrenocorticotropic hormone (ACTH) in a patient with an adrenal incidentaloma is usually attributed to ACTH-independent cortisol secretion. A 71-year-old woman with a 20-mm left adrenal mass had no cushingoid features.
Study · 2026
Growth Hormone-Releasing Peptides: Investigation of Their Secondary Structure, Thermal Stability, and Model Membrane Interactions
Growth hormone-releasing peptides (GHRPs) comprise a group of small synthetic peptides that can effectively influence growth hormone secretion both in humans and animals.
case-report · 2026
Differential reversibility of anterior and posterior pituitary dysfunction in delayed recurrent pediatric Rathke's cleft cyst
Summary Rathke's cleft cyst (RCC) is a benign sellar or suprasellar lesion increasingly detected by magnetic resonance imaging (MRI).